Michael Tanaka is an expert in the field of Hematology. He went to medical school at University of California Davis School of Medicine. University of California Davis School of Medicine is ranked 43/19 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Michael Tanaka is a published doctor. He published 12 publications, including: 'Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study.' Michael Tanaka is registered with Medicare and accepts Medicare payments.
Dr. Gerald L. Denardo, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Kristie A. Bobolis, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Frederick J. Meyers, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. David R. Gandara, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Elias N. Kiwan, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Richard M. Guy, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. M R. Goldberg, MD | |
Dr. Cheryl C. Ho, MD | |
Dr. I-Ting Yu, MD | |
Dr. James D. Kim, MD | |
Srinivas C. Gummaraju, MB | |
Edith A. Perez |